Ibuprofen 2% oral suspension (Berlin-Chemie)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ibuprofen 2% oral suspension (Berlin-Chemie), covering 2025-06-25 to 2025-06-25. Get the full timeline:
Most recent: Clinical Trial Update: A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension [Phase 1]